Pharmafile Logo
Pharmafocus logo
Advanced Search

Genentech shares positive results from global phase 3 trials for crovalimab in PNH

February 7, 2023
Medical Communications

Following the global COMMODORE 2 study, Genentech has announced positive data for crovalimab in treating patients with paroxysmal nocturnal haemoglobinuria …

News

4D Molecular Therapeutics’ Fabry Gene Therapy put on FDA-mandated hold

February 7, 2023
Research and Development

4D Molecular Therapeutics has had its gene therapy programme 4D-310 put on clinical hold by the FDA after adverse side …

News

Strong sales of Basilea’s Cresemba triggers second sales milestone payment from Pfizer

February 7, 2023
Sales and Marketing

Swiss commercial-stage biopharmaceutical company Basilea Pharmaceutica Ltd has announced that continued high sales of its drug Cresemba (isavuconazole) in China …

News

Sage Therapeutics and Biogen Announce FDA Accepts Filing of New Drug Application and Grants Priority Review of Zuranolone in the Treatment of Major Depressive Disorder and Postpartum Depression

February 7, 2023
Business Services

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sage Therapeutics, Inc. (Nasdaq: SAGE) and Biogen Inc. (Nasdaq: BIIB) announced the U.S. Food and Drug Administration (FDA) has accepted …

News
Press release

Oxford Science Enterprises strengthens Life Sciences investment team with appointment of Sanne de Jongh as Partner

February 7, 2023
Business Services

Oxford, UK: February 7, 2023 – Oxford Science Enterprises (OSE), the independent investment company created to found, fund and build transformational businesses …

News
Press release

Chong Kun Dang Pharm Licenses Synaffix ADC Technology, Adds Novel ADC Candidate to Oncology Pipeline

February 6, 2023
Business Services

THE NETHERLANDS and SOUTH KOREA, 6 February 2023 — Synaffix B.V., a biotechnology company focused on commercializing its clinical-stage platform …

News
Press release

Oxford University scientists’ AI diagnostic test accurately identifies known respiratory viruses in minutes

February 6, 2023
Business Services

February 6th, 2023 – Oxford, United Kingdom – Nicolas Shiaelis and 

News
Press release

Patients with hidradenitis suppurativa experienced sustained efficacy and symptom improvement at one year when treated with Novartis Cosentyx®

February 6, 2023
Business Services

Basel, February 4, 2023 – Novartis announced today that The Lancet has published long-term data from the pivotal SUNSHINE and …

News
Press release

SPR Therapeutics gains FDA extended approval for pain management system

February 6, 2023
Research and Development

Pain management medical device company SPR Therapeutics has obtained expanded approval from the FDA for its SPRINT Peripheral Nerve System …

News

Australia’s TGA approves psychedelics to treat mental health conditions

February 6, 2023
Research and Development

Australia’s Therapeutic Goods Administration (TGA) has announced its approval of the use of psychedelics to treat certain mental health conditions. …

News

Daiichi Sankyo to build Japan’s first factory for mRNA COVID-19 vaccines

February 6, 2023
Manufacturing and Production

Daiichi Sankyo have announced its plans to build Japan’s first factory for mRNA COVID-19 vaccines. The new facility is expected …

News

Boston Scientific fined $42m over patent infringement

February 6, 2023
Medical Communications

A five-year legal battle between Boston Scientific and TissueGen has culminated in a $42m fine, which Boston Scientific must pay …

News

Businesses from the UK are in the top four foreign investors in Flanders in 2022

February 3, 2023
Business Services

Investment figures released this week by Flanders Investment & Trade show that UK businesses are continuing to make significant investments …

News
Press release

IMFINZI (DURVALUMAB) IN COMBINATION WITH GEMCITABINE AND CISPLATIN APPROVED IN GREAT BRITAIN AS A FIRST-LINE TREATMENT FOR ADULT PATIENTS WITH LOCALLY ADVANCED, UNRESECTABLE OR METASTATIC BILIARY TRACT CANCER

February 3, 2023
Business Services

London, UK, Thursday 2 February 2023 – AstraZeneca today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has …

News
Press release

MHRA Approves RINVOQ®▼ (upadacitinib) as First Oral Advanced Therapy to Treat Adults with Moderately to Severely Active Crohn’s Disease

February 3, 2023
Business Services

MAIDENHEAD, UK, 01 February 2023 – AbbVie (NYSE: ABBV) today announced that the UK Medicines and Healthcare products Regulatory Agency …

News
Press release

Phlo raises £10m to spearhead digital transformation in pharmacy sector

February 3, 2023
Business Services

[Glasgow, Scotland]  Phlo, UK digital pharmacy leaders, have closed a £10m Series A round led by family office Thairm Bio.   …

News
Press release

Drug-resistant bacteria found in eye drops has infected 55 people in 12 states

February 3, 2023
Medical Communications

A strongly drug-resistant bacteria has been found in multiple brands of artificial tears eyedrops; the most commonly reported was EzriCare …

News

DrugBAN AI expected to reduce costs and speed up drug discovery

February 3, 2023
Medical Communications

In a collaboration between Sheffield University and pharma giant, AstraZeneca, a new AI has been developed which could help deliver …

News

Genoscience Pharma received Orphan Drug Designation for hepatocellular carcinoma drug

February 3, 2023
Medical Communications

French clinical-stage biotech company Genoscience has received FDA Orphan Drug Designation (ODD) for its lead candidate ezurpimtrostat. OOD qualifies the …

News

Insilico Medicine opens new R&D facility in Abu Dhabi

February 3, 2023
Research and Development

Hong Kong-based healthtech company Insilico Medicine recently opened its eighth global laboratory in Abu Dhabi.   Utilising Abu Dhabi’s Masdar …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026